Adenovirus type 4 a

Ended Awarded Last action

Contract number
SPE2DP26F3586
Awardee
Awarding agency
Obligated
$3,950,554

Award facts

Contract value 100% obligated
$3,950,553.60 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Parsippany, NJ 07054, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency Medical Supply Chain issued a $3.95 million delivery order to Teva Pharmaceuticals USA, Inc. on March 18, 2026, for Adenovirus Type 4 vaccine with an ultimate completion date of March 25, 2026.

Place of performance is Parsippany, New Jersey. The order is priced on a firm-fixed-price basis with no set-aside designation. This delivery order was issued under a Defense Logistics Agency Troop Support Medical indefinite delivery contract vehicle that establishes Teva as a critical national supplier of essential pharmaceuticals to federal healthcare systems, with performance extending through August 30, 2027.

Quick answers

Who was awarded contract SPE2DP26F3586?

SPE2DP26F3586 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on March 18, 2026.

How much is contract SPE2DP26F3586 worth?

The government has obligated $3,950,554 on SPE2DP26F3586.

Is contract SPE2DP26F3586 an order under another contract?

Yes. SPE2DP26F3586 is a delivery order under SPE2DP20D0002, an indefinite delivery contract.

Was contract SPE2DP26F3586 competed?

The extent of competition for SPE2DP26F3586 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login